Portal del Investigador
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
Abstract
The SARS-CoV-2 Lambda variant has been prevalent in Latin America. An analysis of the neutralization capacity of antibodies elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in plasma from healthcare workers and patients in Chile reveals that BNT162b2 elicits higher neutralizing antibody titres than CoronaVac.
Más información
| Título según WOS: | Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile |
| Título de la Revista: | NATURE MICROBIOLOGY |
| Volumen: | 7 |
| Número: | 4 |
| Editorial: | NATURE PORTFOLIO |
| Fecha de publicación: | 2022 |
| Página de inicio: | 524 |
| Página final: | + |
| DOI: |
10.1038/S41564-022-01092-1 |
| Notas: | ISI |